Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

7.40
Delayed Data
As of Sep 30
 +0.33 / +4.67%
Today’s Change
4.98
Today|||52-Week Range
14.48
-23.71%
Year-to-Date
3 Biotechs With Potential Big-Time Upside
Sep 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close7.07
Today’s open7.12
Day’s range6.99 - 7.52
Volume1,839,436
Average volume (3 months)2,301,036
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-29.03%
Earnings growth (this year)-12.10%
Earnings growth (next 5 years)+38.44%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.66

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.48+1.63%
RGENRepligen Corp+0.65+2.20%
ARRYArray Biopharma Inc+0.51+8.17%
EGRXEagle Pharmaceutical...+0.03+0.04%
Data as of 4:14pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$0.00
Annual profit (last year)-$132.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts

Search for Jobs